Browse Drug Recalls
188 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 188 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 188 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Mar 28, 2019 | Nystatin Oral Suspension, USP, 100,000 units per mL, 473 mL per bottle, Rx on... | Failed Impurities/Degradation Specifications: Out of Specification for an unknown impurity was ob... | Class III | Akorn, Inc. |
| Feb 22, 2019 | Gentamicin Sulfate Ophthalmic Solution, USP, 0.3%, 5 mL bottle, Rx only, Manu... | Failed Impurities/Degradation Specifications: High Out-of-Specification (OOS) results for Individ... | Class II | Akorn, Inc. |
| Dec 20, 2018 | COSOPT Ophthalmic Solution, USP, (2% Dorzolamide Hydrochloride, 0.5% Timolol ... | Failed Stability Specifications: out of specification results for opalescence at 7 month stabilit... | Class III | Akorn Inc |
| Oct 29, 2018 | Clindamycin Phosphate Topical Solution USP, 1% (10 mg/mL clindamycin), 60 ple... | Failed Impurities/Degradation Specifications; out of specification results observed for other ind... | Class III | Akorn, Inc. |
| Oct 8, 2018 | Gentamicin Sulfate Ophthalmic Solution, USP 0.3%, 5 mL dropper bottle, Rx Onl... | Presence of Particulate Matter: Crystalline particles were noticed at the 24 month clarity testing. | Class II | Akorn, Inc. |
| Aug 24, 2018 | Ethosuximide Capsules, USP, 250 mg, 100 capsules per bottle, Rx only, Mfg For... | Failed Impurities/Degradation Specifications: Out of specification (OOS) results for unspecified ... | Class II | Akorn, Inc. |
| Aug 8, 2018 | Azelastine HCl Ophthalmic Solution 0.05%, 6 mL in 10 mL HDPE bottle, 1 bottle... | Failed Impurities/Degradation Specifications:out-of-specification (OOS) results for Azelastine N-... | Class III | Akorn, Inc. |
| Aug 1, 2018 | Lidocaine 2.5% and Prilocaine Cream, 2.5%. 30g tube, Rx only, Manufactured by... | Failed Impurities/Degredation Specifications: Out of Specification results for an unknown impuri... | Class II | Akorn, Inc. |
| Jun 22, 2018 | Acetylcysteine for Injection 6 g/30 mL (200 mg/mL). Rx Only. Manufactured by ... | CGMP Deviations | Class II | Akorn, Inc. |
| Mar 29, 2018 | Chlorhexidine Gluconate Oral Rinse, 0.12%, 15 mL unit dose cups (NDC 50383-72... | Subpotent Drug: Product crystallization with accompanying low out of specification results for ch... | Class III | Akorn, Inc. |
| Mar 29, 2018 | 24-HOUR Oral Care q4 Kit with Ballard* Technology, containing 2 Toothbrush Pa... | Subpotent Drug: Product crystallization with accompanying low out of specification results for ch... | Class III | Akorn, Inc. |
| Mar 29, 2018 | 24-HOUR Oral Care q2 Kit with Ballard* Technology, containing 2 Toothbrush Pa... | Subpotent Drug: Product crystallization with accompanying low out of specification results for ch... | Class III | Akorn, Inc. |
| Mar 9, 2018 | Triamcinolone Acetonide Lotion, USP 0.1%, 60 mL bottle, Rx Only, Marketed by:... | Failed Impurities/Degradation Specifications: High out of specification results for an impurity. | Class III | Akorn, Inc. |
| Feb 21, 2018 | Atropine Sulfate Ophthalmic 1% Solution, USP, 5mL per bottle, Sterile, Rx Onl... | Failed Stability Specification: OOS low viscosity results discovered during retain testing. | Class III | Akorn, Inc. |
| Apr 20, 2017 | IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit con... | Product is being recalled due to low pH value. | Class III | Akorn, Inc. |
| Mar 17, 2017 | LATANOPROST OPHTHALMIC SOLUTION, 0.005%, 125 ug/2.5 mL, packaged in 2.5 mL b... | Lack of assurance of sterility: product was found to be empty, under-filled, or leaking. | Class II | Akorn, Inc. |
| Oct 21, 2016 | Sodium Chloride Ophthalmic Solution, USP, 5%, 15 mL (0.5 fL oz.) bottle, Akor... | Subpotent Drug: concentration of product is less than labeled amount. | Class II | Akorn Inc |
| Jul 27, 2016 | Desoximetasone Gel USP, 0.05%, packaged in 60 gram aluminum tubes, Rx only, ... | Failed impurities/degradation specifications: product was out of specification for unknown impuri... | Class III | Akorn, Inc. |
| May 17, 2016 | Sulfacetamide Sodium Ophthalmic Solution, USP, 10%, Sterile, Rx Only, 15 mL b... | Lack of Assurance of Sterility; some lots failed Antimicrobial Effectiveness Testing on stability | Class II | Akorn, Inc. |
| Apr 7, 2016 | Good Neighbor Pharmacy PEG-Phen Lubricant Eye Drops (Polyethylene Glycol 400 ... | Presence of Particulate Matter | Class II | Akorn, Inc. |
| Mar 23, 2016 | ORIS (chlorhexidine gluconate), oral rinse, 0.12%, packaged in 16 fl. oz. (47... | Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) ... | Class II | Akorn, Inc. |
| Mar 23, 2016 | PerioRx (chlorhexidine gluconate), oral rinse, 0.12%, packaged in 16 fl. oz. ... | Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) ... | Class II | Akorn, Inc. |
| Mar 23, 2016 | Chlorhexidine gluconate, oral rinse, 0.12% packaged in 16 fl. oz. (473 mL) PE... | Failed impurities/degradation specifications: Out-of-specification result (for multiple batches) ... | Class II | Akorn, Inc. |
| Aug 21, 2015 | Hydrocortisone and Acetic Acid Otic Solution, USP, containing hydrocortisone ... | Defective Container: Product missing safety seal around the neck of the bottle. The product labe... | Class III | Akorn, Inc. |
| Aug 20, 2015 | RIFAMPIN FOR INJECTION USP, 600 mg*/vial, Rx Only. Mfd. for: Akorn, Inc., Lak... | Failed Impurity/Degradation Specifications: Out of Specifications result obtained for a known im... | Class III | Akorn, Inc. |
| Apr 20, 2015 | IC-GREEN (indocyanine green for injection, USP), 25 mg Kit (NDC 17478-701-02,... | Subpotent Drug: Low out-of-specification potency result of the drug product. | Class III | Akorn, Inc. |
| Apr 7, 2015 | Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) b... | Failed Impurities/Degradation Specifications | Class II | Akorn, Inc. |
| Apr 7, 2015 | Hydroxyzine Hydrochloride, oral solution, 10 mg per 5 mL, 16 fl oz (473 ml) b... | Failed Impurities/Degradation Specifications | Class II | Akorn, Inc. |
| Mar 24, 2015 | Fluorescein Sodium Ophthalmic Strips USP, 1.0 mg per strip, labeled as 1) FUL... | Failed Content Uniformity Specifications: The product may not meet finished product release speci... | Class III | Nomax Inc |
| Mar 24, 2015 | Fluorescein Sodium Ophthalmic Strips USP, 0.6 mg per strip, labeled as 1) Flu... | Failed Content Uniformity Specifications: The product may not meet finished product release speci... | Class III | Nomax Inc |
| Mar 17, 2015 | SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP,200 mg/ 40 mg per 5mL,... | Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. | Class II | Akorn, Inc. |
| Mar 17, 2015 | SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP,200 mg/ 40 mg per 5mL,... | Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. | Class II | Akorn, Inc. |
| Mar 17, 2015 | SULFAMETHOXAZOLE AND TRIMETHOPRIM ORAL SUSPENSION, USP 800 mg/ 160 mg per 5mL... | Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. | Class II | Akorn, Inc. |
| Feb 27, 2015 | Fluticasone Propionate Nasal Spray, USP, 50 mcg per spray, in amber glass bo... | Failed Stability Specifications: Out of specification for preservative, benazalkonium chloride. | Class II | Akorn, Inc. |
| Jan 28, 2015 | Erythromycin Pledgets USP, 2%, 60-count jar,Rx only, Manufactured by Ei LLC, ... | Microbial Contamination of Non-Sterile Products: Active Pharmaceutical Ingredient (API) failed US... | Class II | Akorn, Inc. |
| Dec 9, 2014 | Triamcinolone Acetonide Lotion USP, 0.025% is supplied in the following size:... | Failed Impurities/Degradation Specifications: The known impurity went out of specification at 12 ... | Class III | Akorn, Inc. |
| Aug 5, 2014 | Rifampin for Injection USP, 600 mg*/vial (Sterile), supplied in sterile glass... | Failed Impurity/Degradation Specification; high out of specification result for 23 transacetyl im... | Class III | Akorn, Inc. |
| Jun 18, 2012 | Tobramycin Ophthalmic Oint., 0.3%, 5ml bottle, (Generic for: Tobrex), Rx only... | Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as "oi... | Class III | Stat Rx USA |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.